Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03679767
Title A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Incyte Corporation
Indications

renal cell carcinoma

lung non-small cell carcinoma

transitional cell carcinoma

melanoma

Therapies

Retifanlimab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST